Form 4 for HCA HCA Healthcare
Accepted 2024-02-02 00:00:00 ET · period of report 2024-01-31 · accession 0001209191-24-002734 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-02 | 2024-01-31 | HCA | Wyatt Christopher F. | SVP, Ctrl | F - Tax | $304.90 | -6,376 | 41.4K | -13% | -$1.94M |
| DM | 2024-02-02 | 2024-01-31 | HCA | Wyatt Christopher F. | SVP, Ctrl | M - OptEx | $96.75 | +11.7K | 38.8K | +43% | +$1.13M |
| D | 2024-02-02 | 2024-01-31 | HCA | Wyatt Christopher F. | SVP, Ctrl | A - Grant | $0.00 | +4,402 | 4,402 | New | $0 |
| DM | 2024-02-02 | 2024-01-31 | HCA | Wyatt Christopher F. | SVP, Ctrl | M - OptEx | $0.00 | -11.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-31 | F | D | 6,376 | $304.90 | 41,383 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-31 | M | A | 9,000 | $101.16 | 47,759 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-31 | M | A | 2,680 | $81.96 | 38,759 | D | — | — | |
| 4 | Derivative | Stock Appreciation Right | 2024-01-31 | A | A | 4,402 | $0.00 | 4,402 | D | $304.90 · 2025-01-31 to 2034-01-31 | 4,402 Common Stock | (F3) The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. |
| 5 | Derivative | Stock Appreciation Right | 2024-01-31 | M | D | 9,000 | $0.00 | 9,300 | D | $101.16 · — to 2028-01-31 | 9,000 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. |
| 6 | Derivative | Stock Appreciation Right | 2024-01-31 | M | D | 2,680 | $0.00 | 0 | D | $81.96 · — to 2027-02-01 | 2,680 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. |